In the BioHarmony Drug Report Database

"Preview" Icon

Colchicine

Colcrys, Gloperba, Mitigare (colchicine) is a small molecule pharmaceutical. Colchicine was first approved as Colcrys on 2009-07-29. It is used to treat amyloidosis, biliary liver cirrhosis, familial mediterranean fever, and gout in the USA. The pharmaceutical is active against tubulin beta chain. In addition, it is known to target glycine receptor subunit alpha-1, bromodomain-containing protein 4, and glycine receptor subunit alpha-2. Probenecid and colchicine’s patents are valid until 2037-12-20 (FDA).

 

Trade Name

 

Colcrys, Gloperba, Mitigare
 

Common Name

 

colchicine
 

ChEMBL ID

 

CHEMBL107
 

Indication

 

amyloidosis, biliary liver cirrhosis, familial mediterranean fever, gout
 

Drug Class

 

Image (chem structure or protein)

Colchicine structure rendering